Medallion Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$198K Sell
676
-35
-5% -$11.5K 0.06% 255
2025
Q4
$249K Sell
711
-22
-3% -$7.43K 0.08% 214
2025
Q3
$237K Hold
733
0.08% 209
2025
Q2
$289K Buy
733
+109
+17% +$43.8K 0.11% 179
2025
Q1
$270K Hold
624
0.12% 165
2024
Q4
$240K Buy
+624
New +$261K 0.12% 166

Other funds holding ELV

Medallion Wealth Advisors's ELV Position: Q1 2026 in Review

Medallion Wealth Advisors reduced its Elevance Health (ELV) stake by 4.9% in Q1 2026, selling an estimated $11.5K and leaving 676 shares worth $198K. The position accounts for 0.06% of the portfolio, ranked #255.

Medallion Wealth Advisors first reported a position in ELV in Q4 2024 and has held it in 6 quarters since. The position peaked at $289K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Medallion Wealth Advisors held 676 shares of Elevance Health worth $198K as of Q1 2026.
  • Medallion Wealth Advisors sold 35 Elevance Health shares in Q1 2026, an estimated $11.5K.
  • Elevance Health made up 0.06% of Medallion Wealth Advisors's portfolio in Q1 2026, its #255 holding.
  • Medallion Wealth Advisors first reported a position in Elevance Health in Q4 2024 and has held it in 6 quarters since.
  • Medallion Wealth Advisors's Elevance Health position peaked at $289K in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.